Compare · TMO vs USBC
TMO vs USBC
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and USBC Inc. (USBC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both TMO and USBC operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $211.18B, about 1710.9x USBC ($123.4M).
- USBC has been more active in the news (4 items in the past 4 weeks vs 3 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 0 for USBC).
- Company
- Thermo Fisher Scientific Inc
- USBC Inc.
- Price
- -
- -
- Market cap
- $211.18B
- $123.4M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- AMEX
- IPO
- News (4w)
- 3
- 4
- Recent ratings
- 25
- 0
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest TMO
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports Second Quarter 2026 Results
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
Latest USBC
- USBC Expands Team With Former Apple Pay and Cash App Partnerships Lead
- Amendment: SEC Form S-1/A filed by USBC Inc.
- SEC Form DEF 14C filed by USBC Inc.
- Amendment: SEC Form S-1/A filed by USBC Inc.
- USBC Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
- SEC Form PRE 14C filed by USBC Inc.
- USBC Supports FDIC's Proposed Rule to Implement the GENIUS Act
- USBC Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
- SEC Form 10-Q filed by USBC Inc.
- USBC Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits